Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer.

about

Antithyroglobulin Antibody as a Marker of Successful Ablation Therapy in Differentiated Thyroid Cancer.

Item

http://www.wikidata.org/entity/Q36285155

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@ast

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@en

type

Item

label

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@ast

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@en

prefLabel

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@ast

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@en

P1476

Antithyroglobulin Antibody as ...... Differentiated Thyroid Cancer.

@en

P2093

Achmad Hussein Sundawa Kartamihadja

http://www.w3.org/2001/XMLSchema#string

Ayu Rosemeilia Dewi

http://www.w3.org/2001/XMLSchema#string

Basuki Hidayat

http://www.w3.org/2001/XMLSchema#string

Budi Darmawan

http://www.w3.org/2001/XMLSchema#string

Johan S Masjhur

http://www.w3.org/2001/XMLSchema#string

P2860

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Thyroglobulin antibodies in differentiated thyroid cancer.

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.

Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.

Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.

Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning.

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

P304

15-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1450-1147.174714

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28217014

http://www.w3.org/2001/XMLSchema#string

P932

5314657

http://www.w3.org/2001/XMLSchema#string